The key issue is whether the earlier intervention has stopped influencing the outcome before the next measurement period begins. A drug may remain active, or a biological response may persist, so observations during the next period can reflect both interventions. If the interval is too short, comparisons become harder to attribute to the current treatment condition.
Behavioral and physiological responses can delay return to baseline, even when the treatment itself is no longer being administered. Later outcomes may therefore reflect an altered state from the previous period rather than a fresh response. Clinical crossover designs need to consider recovery of direct biological activity as well as associated changes in behavior or physiology.
Treatment sequence and period effects help researchers judge whether the order of interventions or the timing of measurements is influencing results. Carry-over may be more consequential when one intervention precedes another, making the observed comparison dependent on study order. Reviewing these effects supports more accurate interpretation of outcomes from each clinical trial period.
An adequate washout period should allow relevant influences from the earlier period to subside before the next assessment. Researchers should consider whether drug activity, biological responses, behavior, and physiology have returned to baseline. When recovery remains incomplete, measurements in the following period may not represent the current intervention alone.
Investigators can examine whether outcomes differ according to treatment sequence or study period and consider whether the preceding intervention could still affect the current measurement. This assessment is especially important when a washout interval may have been inadequate. The resulting interpretation should account for these influences rather than treating every difference as a current-treatment effect.
They are particularly important in crossover trials, where the same participants receive interventions across multiple periods. Persistent drug, biological, behavioral, or physiological influences can transfer information from one period into the next. Recognizing that possibility helps researchers evaluate whether the intended treatment comparison remains valid and whether conclusions accurately reflect the current intervention.